| Issue Date | Title | Author(s) |
| 2024 | Assessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3- hydroxypyridinium N-acetyltaurinate in the modeling of POAG | Efimenko, S. V.; Korokin, M. V.; Gudyrev, O. S.; Danilenko, L. M.; Korokina, L. V. |
| 2022 | Experimental study of new derivatives of 3-hydroxypyridine as pharmacological agents for the correction of ischemic brain injury after intracerebral hemorrhage | Shcheblykina, O. V.; Shcheblykin, D. V.; Trunov, K. S.; Danilenko, A. P.; Lipatov, V. S. |
| 2021 | Magnesium acetyltaurate prevents retinal damage and visual impairment in rats through suppression of NMDA-induced upregulation of NF-κB, p53 and AP-1 (c-Jun/c-Fos) | Lambuk, L.; Lezhitsa, I.; Renu Agarwal; Peresypkina, A.; Pobeda, A. |
| 2022 | Neuroprotective effects of a 40% ethanol extract of the black walnut bark (Juglans nigra L.) | Pozdnyakov, D. I.; Dayronas, Z. V.; Zolotych, D. S.; Geraschenko, A. D.; Shabanova, N. B. |
| 2022 | Neuroprotective effects of a 40% ethanol extract of the black walnut bark (Juglans nigra L.) | Pozdnyakov, D. I.; Dayronas, Zh. V.; Zolotych, D. S.; Geraschenko, A. D.; Shabanova, N. B. |
| 2019 | Neuroprotective effects of taurine and 3-hydroxypyridine derivatives in the intracerebral hemorrhage model in rats | Nesterova, N. I.; Shcheblykina, O. V.; Kolesnichenko, P. D.; Nesterov, A. V.; Shcheblykin, D. V. |
| 2021 | Peptide KED: molecular-genetic aspects of neurogenesis regulation in Alzheimer’s disease | Khavinson, V. Kh.; Linkova, N. S.; Umnov, R. S. |
| 2022 | Study of neuroprotective activity of new acetylcholinesterase inhibitors TVA and TVS in experimental model of Alzheimer’s disease | Gasparyan, H. V.; Buloyan, S. A.; Harutyunyan, H. A.; Pogosyan, A. E.; Arshakyan, L. M. |
